News

BioWorld2h
Cidara Navigates toward new flu option with phase IIb data
Cidara Therapeutics Inc. will meet with the FDA to discuss strongly favorable phase IIb results from its randomized, ...
Science-Based Medicine17hOpinion
RFK Jr.’s remade ACIP meets: And so it begins (in earnest)…the dismantling of US federal vaccine infrastructure
The newly reconstituted CDC Advisory Committee on Immunization Practices will meet this week. Packed with antivaxxers, the ...
BioWorld39m
Illumina buying Somalogic for up to $425M to boost multiomics assets
In a bid to boost its multiomics holdings, Illumina Inc. reported an agreement to buy proteomics technology company Somalogic ...